
GC42968
BPIQ-II (hydrochloride)
Also known as N-(3-bromophenyl)-1H-imidazo[4,5-g]quinazolin-8-amine;hydrochloride
BPIQ-II is a linear imidazoloquinazoline that potently inhibits the tyrosine kinase activity of the epidermal growth factor receptor (EGFR; IC50 = 8 pM)
ChemicalCAS171179-37-6MW376.6FormulaC15H10BrN5•HCl
- CAS number
- 171179-37-6
- Molecular weight
- 376.6
- Formula
- C15H10BrN5•HCl
- Solubility
- DMF: 10 mg/ml,DMSO: 30 mg/ml,DMSO:PBS (pH 7·2)(1:9): 0·1 mg/ml
- InChIKey
- FENLVGDZGJBHPT-UHFFFAOYSA-N
- Catalogue number
- GC42968
- Brand
- GLPBIO
Computed properties PubChem CID 132988087 · TPSA 66.5 Ų · H-bond donors 3 · H-bond acceptors 4
- TPSA
- 66.5 Ų
- H-bond donors
- 3
- H-bond acceptors
- 4
- Rotatable bonds
- 2
- Heavy atoms
- 22
SMILES C1=CC(=CC(=C1)Br)NC2=NC=NC3=CC4=C(C=C32)NC=N4.Cl
Computed descriptors from PubChem (CID 132988087), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il